Patents expiring in 2035

US 8969370

3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

Theravance Biopharma R&D IP, LLC · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8969367

Crystalline forms of a 3-carboxypropyl-aminotetralin compound

Theravance Biopharma R&D IP, LLC · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8969321

Medical and nutritional applications of highly refined cellulose

Regents of the University of Minnesota · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8969293

Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Rani Therapeutics, LLC · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8969292

High affinity leptins and leptin antagonists

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8969303

Tocotrienol esters

First Tech International Limited · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8969296

TGFP-CAP peptide and its uses

CAREGEN CO., LTD. · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8969077

Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord

The Regents of the University of California · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8968996

Compositions and methods for rapid immunization against dengue virus

Takeda Vaccines, Inc. · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8968785

Surgical compositions

Covidien LP · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8968783

Hydrogel implants with varying degrees of crosslinking

Covidien LP · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8968786

Formation of stable submicron peptide or protein particles by thin film freezing

The Board of Regents of the University of Texas System · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8968756

Fabrication of biscrolled fiber using carbon nanotube sheet

The Board of Regents of the University of Texas System · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8968703

13C-MR detection using hyperpolarised 13C-fructose

The Regents of the University of California · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8969287

Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry

The Regents of the University of California · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8969382

Modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8968729

Date pit composition for the treatment of animals

UNITED ARAB EMIRATES UNIVERSITY · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8968736

Human antibodies to GFRα3 and methods of use thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8975279

Amine salts of laquinimod

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8975287

Methods for using 1,2,4-Oxadiazole benzoic acid compounds

PTC THERAPEUTICS, INC. · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8975416

Antibacterial compounds

Summit Corporation Plc · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8974801

Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate

Amphastar Pharmaceuticals, Inc. · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8974792

Internalizing erbB2 antibodies

The Regents of the University of California · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8975231

Bone morphogenic protein binding peptide

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8974810

Tissue graft compositions and methods for producing same

The Board of Regents of the University of Oklahoma · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8975442

Process for the preparation of and crystalline forms of optical enantiomers of modafinil

Teva Sante · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8975295

Modulation of zinc levels to improve tissue properties

Precision Dermatology, Inc. · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8975300

Ketone compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8975368

Methods for preparing linked peptide rings and peptide nanotubes obtained thereby

United States of America as represented by the Secretary of the Air Force · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8975293

Epigenetic co-repressors of the gamma-globin gene and methods of using same

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8975282

Substituted pyrazolone compounds and methods of use

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8975246

Bile acid or bile salt fatty acid conjugates

GALMED RESEARCH AND DEVELOPMENT LTD · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8975243

Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

The Regents of the University of California · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8975014

Fluorescence detection of poison oak oil

The Regents of the University of California · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8974776

Biodegradable peptide releasing polymers

Covidien LP · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8975260

Pyridazinones, method of making, and method of use thereof

GILEAD CONNECTICUT, INC. · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8975029

Integrin alpha-2 binding agents and use thereof to inhibit cancer cell proliferation

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8974363

Topical medicaments and methods for photodynamic treatment of disease

Provectus Pharmatech, Inc. · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

PT 2303855

CATALYTIC PROCESS FOR ASYMMETRIC HYDROGENATION

BIAL PORTELA & Cª S A [PT] · Granted Wed Mar 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Mar 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980822

Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Rani Therapeutics, LLC · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980268

Methods for treating cancer by administering an anti-Ang-2 antibody

REGENERON PHARMACEUTICALS, INC. · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980907

Dendrimer conjugates

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980266

Serpin fusion polypeptides and methods of use thereof

Inhibrx, Inc. · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8981046

Synthetic cell platforms and methods of use thereof

The Regents of the University of California · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8981057

B-cell stimulating fusion proteins of an antigen with BAFF or APRIL

ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980952

Methods for treating brain swelling with a compound that blocks a non-selective cation channel

The United States of America as Represented by the Dept. of Veterans Affairs · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8979831

Thermochemical ablation system using heat from delivery of electrophiles

Regents of the University of Minnesota · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8980883

Arylpiperazine derivatives and methods of utilizing same

REVIVA PHARMACEUTICALS, INC. · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)